News & Articles

Attend this free webinar to discover new imaging technology that enables true 3D high content analysis

Find out how the Knight Cancer Institute BioLibrary at Oregon Health and Science University approached the challenge to connect samples and data from multiple sites with the help of a single LIMS

Attend this free webinar to discover solutions to improve your data integrity

LabVantage’s purpose-built solution bundles its leading LIMS software with unique features tailored to industry-specific needs

ACD/Labs algorithms will continue to equip ChemSpider with physicochemical property values and chemical nomenclature following ten-year milestone

Gently compressed stacks of graphene form sharp crinkles that carry an electric charge, which could be useful in nanoscale self-assembly and other applications

SelectScience will be attending the AACC Annual Meeting in Chicago, USA, to interview leading scientists and report on the latest technologies

Agreement focuses on an innovative mobile testing solution for in-field analysis of lubricating oils and greases

By partnering with WCRF, SCIEX supports research that benefits cancer patients

Agreement to focus on accelerating campus innovation from lab to real world via UCI Applied Innovation

University of Missouri School of Medicine pilots Roche’s cloud-based NAVIFY Tumor Board solution to streamline & standardize data collection and presentation, enabling faster, better collaboration among oncology care teams

Osaka University researchers design organic photovoltaic polymer using machine learning

Beckman Coulter Diagnostics launches software version 2 - enhancements improve flagging and streamline the quality control processes

The highly anticipated platform was launched by Repositive at AACR annual meeting

New Synapsys microbiology informatics solution will be demonstrated at the event

During the American Association for Cancer Research 2018 Annual Meeting, SelectScience recognized cutting-edge products and technologies advancing life sciences research

The trial demonstrates that first-line pembrolizumab treatment improved overall and progression-free survival rates in patients with metastatic nonsquamous non-small cell lung cancer

The primary endpoint for first-line nivolumab-ipilimumab combo trial indicates improved progression-free survival in patients with advanced non-small cell lung cancer